Stoke Therapeutics director gifts 303,190 stock options
Stoke Therapeutics, Inc. director Seth Loring Harrison reported 16 bona fide gift transfers on July 16, 2026, moving stock options over 303,190 underlying common shares from his direct holdings to the East Pillar 2026 Irrevocable Trust.
Rhea-AI Filing Summary
Stoke Therapeutics, Inc. director Seth Loring Harrison reported 16 bona fide gift transfers on July 16, 2026, moving stock options over 303,190 underlying common shares from his direct holdings to the East Pillar 2026 Irrevocable Trust. The options are fully vested, with exercise prices between $10.90 and $40.37 and expirations from 2029 to 2036. The gifts were made for no consideration and are exempt from short-swing profit liability under Rule 16b-5.
Positive
- None.
Negative
- None.
Insider Trade Summary
303,190 shares gifted
Gift
16 txns
Insider
Harrison Seth Loring
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Stock Option (Right to Buy) F1, F2 | 29,555 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F2, F3 | 29,555 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F4 | 14,777 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F4, F3 | 14,777 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F5 | 11,650 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F5, F3 | 11,650 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F6 | 21,000 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F6, F3 | 21,000 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F7 | 19,441 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F7, F3 | 19,441 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F8 | 7,639 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F8, F3 | 7,639 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F9 | 29,747 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F9, F3 | 29,747 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F10 | 17,786 | $0.00 | $0.00 |
| Gift | Stock Option (Right to Buy) F1, F10, F3 | 17,786 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 contracts (Direct);
Stock Option (Right to Buy) — 151,595 contracts (Indirect, By Trust)
Footnotes (10)
- F1. The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended.
- F2. This option is fully vested and exercisable. Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on March 21, 2022.
- F3. The securities are directly held by the East Pillar 2026 Irrevocable Trust (the "Trust"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity. The reporting person and certain of his immediate family members are beneficiaries of the Trust.
- F4. This option is fully vested and exercisable. Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2021.
- F5. This option is fully vested and exercisable. Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 8, 2022.
- F6. This option is fully vested and exercisable. Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 7, 2023.
- F7. This option is fully vested and exercisable. Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 13, 2024.
- F8. This option is fully vested and exercisable. Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2025.
- F9. This option is fully vested and exercisable. Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2026.
- F10. The option shall vest in full on the earlier of: (i) June 3, 2027 or (ii) the date of the Issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the Issuer on the vesting date.
Key Figures
Gifted option shares: 303,190 shares
Gift transactions: 16 transactions
Lowest exercise price: $10.90 per share
+2 more
5 metrics
Gifted option shares
303,190 shares
Aggregate underlying common shares in 16 bona fide gift transactions on 2026-07-16
Gift transactions
16 transactions
Number of derivative gifts (code G) of stock options reported
Lowest exercise price
$10.90 per share
Stock option grant expiring on 2035-06-02
Highest exercise price
$40.37 per share
Stock option grant expiring on 2031-06-07
Latest option expiration
2036-06-02
Expiration of option with $29.46 exercise price
Key Terms
bona fide gift, Rule 16b-5, short-swing profit liability, East Pillar 2026 Irrevocable Trust
4 terms
bona fide gift regulatory
"Transaction code G is described as a bona fide gift of securities"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Rule 16b-5 regulatory
"Exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act"
short-swing profit liability regulatory
"Gift is exempt from short-swing profit liability pursuant to Rule 16b-5"
East Pillar 2026 Irrevocable Trust financial
"The securities are directly held by the East Pillar 2026 Irrevocable Trust"
FAQ
What insider transaction did Stoke Therapeutics (STOK) report for Seth Loring Harrison?
Stoke Therapeutics reported that director Seth Loring Harrison made 16 bona fide gifts of stock options on July 16, 2026, transferring options over 303,190 underlying common shares from his direct ownership to a trust, with no consideration received.
Who now holds the gifted Stoke Therapeutics (STOK) options reported in this filing?
The options are held indirectly by the East Pillar 2026 Irrevocable Trust. The filing states the securities are directly held by the trust, and Harrison, as a member of the trustee’s board of managers, may share voting and investment discretion and is a beneficiary.
What are the exercise prices and expirations of the gifted STOK stock options?
The gifted stock options have exercise prices ranging from $10.90 to $40.37 per share, with expiration dates between 2029-09-09 and 2036-06-02. Footnotes state each option grant involved is fully vested and exercisable as of specified prior vesting dates.
Are the Stoke Therapeutics (STOK) gift transactions exempt from short-swing rules or tied to a 10b5-1 plan?
The filing notes the gifts are exempt from short-swing profit liability under Rule 16b-5. The Rule 10b5-1 checkbox is not affirmed (set to false), indicating these transactions were not represented as being made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
